Abstract:Recent studies in our laboratory have found that activation of inflammasomes may turn on the inflammatory response to homocysteine (Hcys), leading to podocyte dysfunction and glomerular sclerosis. The present study was designed to test whether NADPH oxidase-mediated redox signaling contributes to Hcys-induced inflammasome activation in podocytes. By confocal microscopy, Hcys treatment was found to induce inflammasome formation and activation, as shown by an approximate 2.5-fold increase in colocalization between the 3 major inflammasome components - NALP3, apoptosis-associated speck-like protein (ASC), and caspase-1. Accompanying such aggregation of inflammasome components, caspase-1 activity was doubled and IL-1β production was markably increased (1.05±0.12 vs. 0.39±0.06 pg/ml of control). All of these changes in podocytes were significantly blocked by silencing the ASC gene or by inhibition of NADPH oxidase using apocynin, gp91phox peptide, and gp91phox siRNA. Using electromagnetic spin resonance spectrometry, Hcys-induced superoxide production was considerably inhibited by 60% with gp91phox siRNA. In wild type mice with hyperhomocysteinemia (hHcys) induced by folate-free diet, NALP3, ASC, and caspase-1 aggregation in the glomeruli was found at an early stage, which occurred in podocytes as shown by colocalization with podocyte marker such as podocin. In gp91phox knockout mice, however, hHcys-induced inflammasome formation and activation were not observed. These results suggest that Hcys-induced NADPH oxidase activation is importantly involved in the switching on process of NALP3 inflammasomes in podocytes (supported by NIH grants HL057244 and DK54927).

NADPH Oxidase‐Mediated Activation of Inflammasomes by Increased Homocysteine in Mouse Podocytes and Glomeruli